Related Experiment Video
Updated: Aug 19, 2025
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
Published on: June 8, 2019
Noninvasive prenatal screening for cystic fibrosis using circulating trophoblasts: Detection of the 50 most common
Line Dahl Jeppesen1,2, Dorte Launholt Lildballe2,3, Lotte Hatt1
1ARCEDI, Vejle, Denmark.
Objectives:
Cystic fibrosis (CF) is one of the most common severe autosomal recessive disorders. Prenatal or preconception CF screening is offered in some countries. A maternal blood sample in early pregnancy can provide circulating trophoblasts and offers a DNA source for genetic analysis of both the mother and the fetus. This study aimed to develop a cell-based noninvasive prenatal test (NIPT) to screen for the 50 most common CF variants.
Methods:
Blood samples were collected from 30 pregnancies undergoing invasive diagnostics and circulating trophoblasts were harvested in 27. Cystic fibrosis testing was conducted using two different methods: by fragment length analysis and by our newly developed NGS-based CF analysis.
Results:
In all 27 cases, cell-based NIPT provided a result using both methods in agreement with the invasive test result.
Conclusion:
This study shows that cell-based NIPT for CF screening provides a reliable result without the need for partner- and proband samples.
Related Concept Videos
01:23Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
02:46Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...